Patent · US Active

Peptide compositions

US12077612B2 · kind B2 · utility

0Cited by

12References

6Claims

0Family size

Assignee

RHYTHM PHARMACEUTICALS, INC. · US

Inventors

Shubh D. Sharma · Cranbury, US
Leonardus H. T. Van Der Ploeg · Newton, US
Bart Henderson · Belmont, US

Key dates

Filing date	Oct 26, 2020
Grant date	Sep 3, 2024
Priority date	—
Expiry date	Oct 8, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K38/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to polypeptide compounds that are modulators (e.g., agonists and antagonists) of the melanocortin-4 receptor (MC4R) and pharmaceutical compositions comprising same. The compounds described herein are polypeptide of the following structural Formula (I): or a pharmaceutically acceptable salt thereof. Values and preferred values of the variables in structural Formula (I) are described herein.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.